What new therapies are in the pipeline for chronic lymphocytic leukemia (CLL)? What is the side effect profile for novel agents? CLL specialist and dedicated researcher Dr. Nicole Lamanna, from Columbia University Medical Center, shares insight on the latest treatment developments and progress in clinical trials. With a hopeful outlook, Dr. Lamanna describes new therapies under investigation, recent drug approvals and how to sequence novel agents to reduce toxicities. Watch now to hear expert updates on CLL therapy.